Who is sponsoring NCT06823414?

NCT06823414 is sponsored by Alejandra García-Novoa.

What drugs are being tested in NCT06823414?

Interventions in NCT06823414: Video assisted mastectomy.

What condition does NCT06823414 study?

NCT06823414 studies Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer Non-invasive Breast Cancer, High Risk Breast Carcinoma.

Is NCT06823414 still recruiting?

NCT06823414 is currently recruiting now. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT06823414

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy

Recruiting now Last updated 12 February 2025

What this trial tests

trial testing Video assisted mastectomy in Breast Cancer Early Stage Breast Cancer (Stage 1-3) in 126 participants. Currently enrolling.

Timeline

1 February 2025

Primary endpoint
1 April 2029

1 April 2034

Quick facts

Lead sponsor	Alejandra García-Novoa
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	126
Start date	1 February 2025
Primary completion	1 April 2029
Estimated completion	1 April 2034
Sites	1 location across Spain

Drugs / interventions tested

Video assisted mastectomy

Conditions studied

Breast Cancer Early Stage Breast Cancer (Stage 1-3) — all drugs for Breast Cancer Early Stage Breast Cancer (Stage 1-3) →
Breast Cancer Non-invasive Breast Cancer — all drugs for Breast Cancer Non-invasive Breast Cancer →
High Risk Breast Carcinoma — all drugs for High Risk Breast Carcinoma →

Sponsor

Alejandra García-Novoa

Who can join

18 and older, female only, with Breast Cancer Early Stage Breast Cancer (Stage 1-3) or Breast Cancer Non-invasive Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-inferiority study of video-assisted (endoscopic or robotic) skin- and nipple-sparing mastectomy compared to open mastectomy. The feasibility of the technique, oncological safety and cosmetic results will be studied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Currently open trials in the same condition.

NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
NCT06781996 — A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuva · Phase 3 · recruiting
NCT06970912 — ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer · Phase 2 · recruiting
NCT07206394 — Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome. · NA · recruiting
NCT06995118 — The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06823414 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alejandra García-Novoa
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06823414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing